GeneDx Holdings (WGS) Cash from Investing Activities (QoQ) (2020 - 2026)
Powered by 
Analysis
GeneDx Holdings (WGS) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.37% |
| Mar 31, 2026 | -55.84% |
| Dec 31, 2025 | -136.23% |
| Sep 30, 2025 | 87.11% |
| Jun 30, 2025 | -286.37% |
| Mar 31, 2025 | -1,712.72% |
| Dec 31, 2024 | 93.31% |
| Sep 30, 2024 | 65.84% |
| Jun 30, 2024 | -2,792.88% |
| Mar 31, 2024 | 117.33% |
| Dec 31, 2023 | 82.07% |
| Sep 30, 2023 | -140.70% |
| Jun 30, 2023 | -2,339.61% |
| Mar 31, 2023 | 83.72% |
| Dec 31, 2022 | 33.66% |
| Sep 30, 2022 | 96.72% |
| Jun 30, 2022 | -3,229.85% |
| Mar 31, 2022 | 49.14% |
| Dec 31, 2021 | -112.63% |
| Sep 30, 2021 | 19.26% |